Benzinga | Nov 16, 2021 08:31AM EST

Legend Biotech Q3 EPS $(0.43) Down From $(0.25) YoY, Sales $16.90M Up From $11.75M YoY

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.43) per share. This is a 72 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $16.90 million in sales this quarter. This is a 43.87 percent increase over sales of $11.75 million the same period last year.